Previous findings show that circulating irisin level is lower in patients with chronic heart failure (Silvestrini et al., 2019), middle cerebral artery occlusion (MCAO) patients (Li et al., 2017), and subjects with Alzheimer disease (AD) (Kim et al., 2018) compared with normal subjects. The gene discussed is FNDC5; the disease is Alzheimer disease.